Mitchell Mcleod Pugh & Williams Inc. lessened its holdings in shares of Clorox Co (NYSE:CLX) by 9.4% in the 1st quarter, HoldingsChannel reports. The fund owned 5,954 shares of the company’s stock after selling 620 shares during the quarter. Mitchell Mcleod Pugh & Williams Inc.’s holdings in Clorox were worth $955,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. Webster Bank N. A. boosted its holdings in Clorox by 5.6% in the 1st quarter. Webster Bank N. A. now owns 19,920 shares of the company’s stock valued at $3,197,000 after purchasing an additional 1,052 shares during the last quarter. Old North State Trust LLC boosted its holdings in Clorox by 6.6% in the 1st quarter. Old North State Trust LLC now owns 1,870 shares of the company’s stock valued at $300,000 after purchasing an additional 115 shares during the last quarter. Pacer Advisors Inc. acquired a new position in Clorox in the 1st quarter valued at about $1,966,000. Manning & Napier Group LLC lifted its holdings in shares of Clorox by 29.0% in the 1st quarter. Manning & Napier Group LLC now owns 60,684 shares of the company’s stock worth $9,736,000 after acquiring an additional 13,627 shares during the last quarter. Finally, TrimTabs Asset Management LLC lifted its holdings in shares of Clorox by 5.0% in the 1st quarter. TrimTabs Asset Management LLC now owns 9,457 shares of the company’s stock worth $1,517,000 after acquiring an additional 448 shares during the last quarter. 76.89% of the stock is owned by institutional investors.

Shares of NYSE:CLX traded up $1.74 during trading hours on Thursday, reaching $155.53. The stock had a trading volume of 17,690 shares, compared to its average volume of 911,688. Clorox Co has a 1 year low of $113.57 and a 1 year high of $167.70. The company has a current ratio of 1.15, a quick ratio of 0.66 and a debt-to-equity ratio of 3.08. The company has a market cap of $19.71 billion, a PE ratio of 24.84, a P/E/G ratio of 3.80 and a beta of 0.32.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Monday, February 4th. The company reported $1.40 EPS for the quarter, beating the Zacks’ consensus estimate of $1.32 by $0.08. Clorox had a net margin of 12.65% and a return on equity of 105.97%. The company had revenue of $1.47 billion for the quarter, compared to the consensus estimate of $1.47 billion. During the same period in the prior year, the firm posted $1.77 EPS. The company’s quarterly revenue was up 4.0% compared to the same quarter last year. As a group, equities research analysts expect that Clorox Co will post 6.32 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Friday, May 10th. Investors of record on Wednesday, April 24th will be given a $0.96 dividend. This represents a $3.84 dividend on an annualized basis and a dividend yield of 2.47%. The ex-dividend date is Tuesday, April 23rd. Clorox’s dividend payout ratio (DPR) is 61.34%.

CLX has been the topic of several recent analyst reports. Zacks Investment Research upgraded shares of Clorox from a “hold” rating to a “buy” rating and set a $177.00 price objective on the stock in a report on Monday, March 11th. BMO Capital Markets set a $175.00 price objective on shares of Clorox and gave the stock a “buy” rating in a report on Tuesday, February 5th. Wells Fargo & Co restated a “hold” rating and issued a $157.00 price objective on shares of Clorox in a report on Monday, February 4th. Barclays restated a “hold” rating and issued a $142.00 price objective on shares of Clorox in a report on Wednesday, February 6th. Finally, Citigroup set a $171.00 price objective on shares of Clorox and gave the stock a “hold” rating in a report on Tuesday, February 5th. Six research analysts have rated the stock with a sell rating, five have assigned a hold rating and four have issued a buy rating to the company’s stock. Clorox currently has a consensus rating of “Hold” and an average price target of $151.21.

In related news, SVP Andrew J. Mowery sold 5,340 shares of the stock in a transaction on Friday, March 1st. The shares were sold at an average price of $156.44, for a total value of $835,389.60. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, SVP Matthew T. Laszlo sold 10,585 shares of the stock in a transaction on Wednesday, February 6th. The shares were sold at an average price of $153.89, for a total transaction of $1,628,925.65. Following the completion of the transaction, the senior vice president now directly owns 17,994 shares in the company, valued at $2,769,096.66. The disclosure for this sale can be found here. Company insiders own 1.40% of the company’s stock.

WARNING: This piece was first published by Watch List News and is the property of of Watch List News. If you are viewing this piece on another site, it was stolen and republished in violation of U.S. & international copyright & trademark legislation. The legal version of this piece can be viewed at https://www.watchlistnews.com/mitchell-mcleod-pugh-williams-inc-reduces-position-in-clorox-co-clx/2955250.html.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

Featured Article: Index Funds

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.